![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
20
F.i.s. - Fabbrica Italiana Sintetici S.p.a. Montecchio Maggiore It, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Flurazepam monohydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2001-232 - Rev 03
This Chemical Type CEP, issued on April 05, 2018, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 905 associated with this CEP further emphasizes